Use national and Coordinate administration Facilitate antiviral resistance Prescribe and deliver antivirals Antivirals international antiviral of antivirals. testing [PHLN]. Conduct according to NMS and state resistance patterns, disease Use national guidelines and surveillance of antiviral policy. severity data and data on at health service capacity adverse event monitoring Conduct resistance tests risk populations to inform assessment to inform policy [TGA/CDNA]. [WHOCC, NICs]. policy on NMS. on jurisdictional stockpile Provide advice concerning Provide input into discussions items. the use and distribution of concerning effectiveness, antivirals [CDNA/ AHPPC]. and dissemination of Provide advice concerning antivirals [GPs, hospitals, the use of antivirals in infants pharmacists, and children, pregnant and WHOCC]. lactating women Use existing trial [CDNA/AHPPC]. networks/academic collaborations to assemble and analyse evidence concerning current and best practice [academia].
Antivirals Use national and international antiviral resistance patterns, disease severity data and data on at risk populations to inform policy on NMS. Coordinate administration of antivirals. Use national guidelines and health service capacity assessment to inform policy on jurisdictional stockpile items. Facilitate antiviral resistance testing [PHLN]. Conduct surveillance of antiviral adverse event monitoring [TGA/CDNA]. Provide advice concerning the use and distribution of antivirals [CDNA/ AHPPC]. Provide advice concerning the use of antivirals in infants and children, pregnant and lactating women [CDNA/AHPPC]. Prescribe and deliver antivirals according to NMS and state policy. Conduct resistance tests [WHOCC, NICs]. Provide input into discussions concerning effectiveness, and dissemination of antivirals [GPs, hospitals, pharmacists, WHOCC]. Use existing trial networks/academic collaborations to assemble and analyse evidence concerning current and best practice [academia].
w-AHMPPI.docx